Indian CRDMOs with technical expertise handle complexities of advanced biologics: Alok Mehrotra
Precision and Progress: A Retrospective on CRDMOs in 2024
The Great Pharma Supply Chain Realignment
Developing a Complex, First-of-its-kind Antiparasitic Drug for Dogs
Can India Leverage US Biosecure Act to Strengthen CRDMOs?
Syngene Intl CFO says 25-30% of clients seeking alternatives to China supply chains; co looking to diversify
Syngene: FY25 guidance intact as biotech funding revives
biologics Roundtable: the current landscape and future developments
The Role of Quality Management in Modern CRDMOs
BIOSECURE Act: Companies turn to US manufacturers
